Hospital Universitario De Toledo — Clinical Trial Site

85 Registered trials

30 Currently recruiting

Organisation

Hospital Universitario De Toledo

Location

Toledo, Spain

Identifier

ORG-100044299

Address

Avenue Del Rio Guadiana Sn, 45007, Spain

Departments

724003; Cardiology
Allergology
Anestesia
Cardiologia
Cardiology
Cardiology Service
Critical Care Unit
Dept. of Cardiology
Dermatology
Digestive System Service
Hematologia
Hematology
Intensive Care
Intensive Medicine
Investigación Clinica Oncológica
Medical Oncology
N/A
NA
Nephrology
Neumology
Neurology
Nuclear Medicine
Oncología
Oncology
Oncology Service
Pediatric
Pediatrics
Pneumology Service
Pulmonary Hypertension Unit
Pulmorany Arterial Hypertension Unit
Servicio de Hematología
Servicio de Oncología - Investigación Clínica
Vascular Surgery

Clinical trials at this site (85)

Search interface

SAKK 08/23: Addition of Darolutamide to first line treatment of mCRPC: a randomized open label phase II trial Recruiting

2024-512132-29-00 Metastatic castration-resistant prostate cancer 4 2025-08-06
Cetuximab With or Without Paclitaxel After Pembrolizumab-Chemotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck. Recruiting

2024-514953-31-00 Recurrent/Metastatic Squamous Cell Carcinoma of the Hea 4 2025-05-20
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer … Recruiting

2024-512279-10-00 Triple Negative Breast Cancer 5 2024-11-25
Beta-Blockers in Takotsubo Syndrome: A Randomized Clinical Trial Recruiting

2023-510213-25-01 Takotsubo Syndrome (TT) is an acute cardiac condition 6 2024-07-08
Phase II study of axitinib intensification plus standard of care (SOC) compared to SOC alone after induction with nivolumab plus ipilimumab … Recruiting

2024-511397-70-00 metastatic renal cell carcinoma (mRCC) 4 2024-05-06
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF)… Recruiting

2023-504323-25-01 breast cancer 5 2024-03-19
A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 Follicular lymphoma 5 2024-02-01
Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo i… Recruiting

2024-510959-35-00 Parkinson's disease 4 2023-09-07
A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR) Recruiting

2024-513562-19-00 End-Stage Kidney Disease 5 2023-08-30
Randomized phase 2 study of Valproic acid combinEd with Simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic P… Recruiting

2024-518710-11-00 Metastatic pancreatic ductal adenocarcinoma (mPDAC) 4 2023-06-12
Multicenter, randomized, double-blind, comparative clinical trial to assess the efficacy of Zinc Acexamate versus a placebo in improving the… Recruiting

2024-518242-24-00 Chronic liver disease 5 2022-06-27
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
LONG-TERM FOLLOW-UP STUDY OF EARLY STAGE BREAST CANCER PATIENTS INCLUDED IN GEICAM STUDIES Recruiting

2022-502706-33-00 Patients with invasive breast cancer in early stages 6 2018-01-10
A clinical study of sotatercept in people with pulmonary arterial hypertension (MK-7962-038) Ended

2025-521970-33-00 Pulmonary Arterial Hypertension (PAH) 5 2025-12-19
A clinical study of sotatercept in people with pulmonary arterial hypertension Ended

2024-518687-12-00 Pulmonary Arterial Hypertension (PAH) 4 2025-06-19
A clinical study of sotatercept in people with pulmonary hypertension (MK-7962-023) Ended

2024-515773-99-00 Pulmonary Hypertension 4 2025-05-26
A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension… Ended

2024-513991-16-00 Pulmonary Hypertension Associated with Interstitial Lun 4 2025-01-17
An open label, single-arm, phase 2 study of perioperative sacituzumab govitecan in combination with zimberelimab and domvanalimab for patien… Ended

2023-504420-26-00 Bladder Cancer 4 2025-01-13
A 24-Week Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF) (… Ended

2024-514283-40-00 Pulmonary Hypertension 4 2024-12-19
An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arte… Ended

2023-506334-75-00 Pulmonary Arterial Hypertension 5 2024-07-12
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Ended

2023-508235-31-00 Atopic Dermatitis 5 2024-06-17
A Phase 2, open-label, multi-centre, multi-national interventional trial to evaluate the efficacy and safety of erdafitinib (ERDA) monothera… Ended

2024-512573-27-01 Muscle-invasive bladder cancer (MIBC) 4 2023-12-11
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Ended

2022-501024-20-00 ER+/HER2- Early Breast Cancer 5 2023-07-25